Lowenstein Sandler is representing its client Princeton Pharma Holdings LLC and its wholly owned subsidiary, Aton Pharma, Inc., in the pending acquisition of Princeton Pharma by Valeant Pharmaceuticals International, a public pharmaceutical company. The $318 million, all cash deal, closed in May 2010. More ...

Lowenstein Sandler PC is serving as co-counsel to IT services company Intelligroup, Inc., in its recently announced merger with NTT DATA Corporation, a Japan-based IT services company. NTT DATA will acquire Intelligroup for approximately $199 million through an all-cash tender offer, followed by a second-step merger to acquire all remaining shares at the same price paid. The Lowenstein Sandler team includes Steven Skolnick, Meredith Prithviraj and Andrea Brown.

Lowenstein Sandler has won motions to dismiss amended complaints filed by the third-party payors and consumer plaintiffs in multidistrict litigation class actions involving oncology drugs Temodar and Intron. Lowenstein represented defendant Schering-Plough (now Merck) in the putative class action, which sought damages for the alleged "off-label" marketing of the two drugs. In June 2010, the federal district court for the District of New Jersey dismissed the class action complaints with prejudice, More...

Lowenstein Sandler ranks among the nation's most active law firms for the number of private equity and venture capital deals negotiated and closed during 2009, according to Dow Jones Private Equity Analyst. The firm was recognized for handling 89 private equity and venture capital deals and was highlighted for its representation of Insight Venture Partners, lead investor in the recent $100 million investment in Twitter. More ...